Profound Medical Corp. (PROF) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 69.76M | 104.21M | 41.52M | 48.81M | 59.91M | 69.06M | 40.88M | 66.34M | 74.71M | 55.51M | 48.09M | 54.6M |
| Cash & Short-Term Investments | 50.46M | 81.8M | 24.83M | 35.2M | 46.43M | 54.91M | 27.12M | 46.63M | 55.78M | 34.73M | 33.46M | 39.21M |
| Cash Only | 50.46M | 81.8M | 24.83M | 35.2M | 46.43M | 54.91M | 27.12M | 46.63M | 55.78M | 34.73M | 33.46M | 39.21M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 9.45M | 9.86M | 8.17M | 4.9M | 5.97M | 7.04M | 7.03M | 9.23M | 7.82M | 8.95M | 6.59M | 6.57M |
| Days Sales Outstanding | 165.15 | 138.74 | 113.62 | 223.57 | 223.39 | 121.55 | 195.34 | 347.51 | 530.17 | 268.48 | 350.37 | 385.4 |
| Inventory | 9.03M | 11.28M | 8.34M | 8.35M | 6.79M | 5.8M | 6.43M | 9.21M | 9.45M | 9.26M | 7.39M | 8.04M |
| Days Inventory Outstanding | 615.92 | 454.44 | 565.35 | 1.16K | 738.05 | 331.5 | 518.72 | 1.05K | 1.49K | 566.7 | 1.06K | 1.33K |
| Other Current Assets | 813.67K | 1.27M | 195K | 0 | 0 | 0 | 0 | 566.44K | 360.31K | 707.54K | 644.89K | 774.65K |
| Total Non-Current Assets | 3.94M | 88.73M | 781K | 857K | 952K | 1.17M | 1.35M | 2.11M | 2.55M | 2.73M | 2.12M | 2.11M |
| Property, Plant & Equipment | 3.59M | 225K | 578K | 581K | 651K | 821.01K | 1.02M | 1.6M | 1.97M | 2.08M | 1.59M | 1.52M |
| Fixed Asset Turnover | 2.76x | 14.89x | 9.13x | 3.59x | 3.56x | 5.78x | 2.92x | 1.25x | 0.71x | 1.45x | 1.11x | 1.01x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 129.42K | 138K | 123K | 175K | 214K | 261K | 329K | 511.71K | 579.74K | 649.24K | 527.46K | 590.97K |
| Long-Term Investments | 150.49K | 410.89K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 0 | 87.96M | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 |
| Total Assets | 73.7M | 192.94M | 42.3M | 49.67M | 60.86M | 70.23M | 42.23M | 68.45M | 77.26M | 58.24M | 50.2M | 56.71M |
| Asset Turnover | 0.04x | 0.05x | 0.12x | 0.04x | 0.04x | 0.09x | 0.07x | 0.03x | 0.02x | 0.05x | 0.03x | 0.03x |
| Asset Growth % | 21.09% | 174.71% | 0.17% | -27.44% | -21.23% | 20.59% | -15.87% | 20.72% | 26.16% | -9.55% | -22.31% | -22.47% |
| Total Current Liabilities | 10.64M | 8.32M | 9.94M | 5.72M | 5.29M | 6.57M | 6.68M | 7.7M | 7.91M | 8.44M | 5.16M | 10.96M |
| Accounts Payable | 2.15M | 2.14M | 717K | 949K | 1.05M | 1.32M | 3.4M | 3.65M | 734.16K | 1.15M | 2.01M | 2.42M |
| Days Payables Outstanding | 130.07 | 66.19 | 56.43 | 153.23 | 138.57 | 127.69 | 233.75 | 245.97 | 149.31 | 107.3 | 304.79 | 368.93 |
| Short-Term Debt | 4.59M | 291.73K | 277K | 0 | 0 | 1.74M | 2.2M | 2.77M | 2.78M | 2.79M | 2.14M | 7.57M |
| Deferred Revenue (Current) | 465.53K | 609.49K | 434K | 694K | 636K | 419K | 801K | 0 | 0 | 0 | 669.77K | 650.87K |
| Other Current Liabilities | 1.69M | 2.01M | 8.51M | 3.29M | 2.4M | 1.03M | 0 | 924.91K | 889.93K | 955.3K | 0 | 0 |
| Current Ratio | 6.56x | 12.52x | 4.18x | 8.53x | 11.31x | 10.52x | 6.12x | 8.61x | 9.44x | 6.58x | 9.32x | 4.98x |
| Quick Ratio | 5.71x | 11.17x | 3.34x | 7.07x | 10.03x | 9.64x | 5.16x | 7.42x | 8.25x | 5.48x | 7.88x | 4.25x |
| Cash Conversion Cycle | 651 | 526.99 | 622.53 | 1.23K | 822.86 | 325.36 | 480.3 | 1.15K | 1.87K | 727.89 | 1.11K | 1.35K |
| Total Non-Current Liabilities | 3.44M | 93.63M | 224K | 4.68M | 4.78M | 3.25M | 4.49M | 7.07M | 7.7M | 8.43M | 6.66M | 1.46M |
| Long-Term Debt | 0 | 6.16M | 0 | 4.46M | 4.49M | 2.92M | 3.4M | 5.39M | 6M | 6.62M | 5.32M | 0 |
| Capital Lease Obligations | 2.9M | 0 | 0 | 72K | 136K | 203K | 365K | 584.23K | 581.1K | 667.78K | 625.99K | 706.77K |
| Deferred Tax Liabilities | 0 | 86.83M | 0 | 0 | 0 | 0 | 59K | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 92.3K | 108.2K | 224K | 77K | 72K | 71K | 0 | 1.09M | 1.12M | 1.14M | 0 | 0 |
| Total Liabilities | 14.08M | 101.95M | 10.16M | 10.41M | 10.07M | 9.81M | 11.17M | 14.77M | 15.61M | 16.87M | 11.83M | 12.42M |
| Total Debt | 7.49M | 6.45M | 277K | 4.81M | 4.88M | 5.12M | 6.23M | 9.1M | 9.7M | 10.42M | 8.09M | 8.27M |
| Net Debt | -42.97M | -75.34M | -24.55M | -30.38M | -41.55M | -49.79M | -20.89M | -37.53M | -46.08M | -24.31M | -25.38M | -30.93M |
| Debt / Equity | 0.13x | 0.07x | 0.01x | 0.12x | 0.10x | 0.08x | 0.20x | 0.17x | 0.16x | 0.25x | 0.21x | 0.19x |
| Debt / EBITDA | - | - | - | - | - | - | 0.50x | - | - | - | - | 1.23x |
| Net Debt / EBITDA | - | - | - | - | - | - | -1.69x | - | - | - | - | -4.61x |
| Interest Coverage | - | - | - | - | - | -30.03x | -61.08x | -46.85x | -16.72x | -34.04x | - | -33.08x |
| Total Equity | 59.62M | 90.99M | 32.14M | 39.26M | 50.79M | 60.42M | 31.06M | 53.69M | 61.65M | 41.37M | 38.38M | 44.29M |
| Equity Growth % | 17.38% | 50.59% | 3.47% | -26.87% | -17.62% | 46.05% | -19.05% | 21.22% | 26.51% | -20.41% | -35.71% | -34.86% |
| Book Value per Share | 1.64 | 2.96 | 1.07 | 1.31 | 1.69 | 2.34 | 1.26 | 2.20 | 2.59 | 1.94 | 1.79 | 2.09 |
| Total Shareholders' Equity | 59.62M | 90.99M | 32.14M | 39.26M | 50.79M | 60.42M | 31.06M | 53.69M | 61.65M | 41.37M | 38.38M | 44.29M |
| Common Stock | 325.23M | 443.54M | 282.75M | 281.64M | 281.64M | 281.55M | 235.67M | 315.84M | 329.54M | 294.41M | 211.59M | 215.72M |
| Retained Earnings | -295.76M | -394.1M | -279.57M | -271.59M | -255.89M | -245.17M | -240.41M | -316.12M | -303.33M | -287.99M | -208.02M | -203.1M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 4.03M | 6.88M | 4.75M | 5.56M | 2.85M | 2.74M | 16.39M | 26.42M | 6.23M | 7.37M | 16.51M | 12.65M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |